The University of Texas Medical Branch · 4 months ago
MRI Technologist I - Galveston (Fri-Sun 7:00pm to 7:30am)
The University of Texas Medical Branch is a leading medical institution in Texas, dedicated to providing exceptional healthcare and education. They are seeking a Magnetic Resonance Imaging Technologist I who will work independently to perform routine MR procedures and assist physicians with diagnostic and special MR procedures, ensuring optimal patient care and safety.
Responsibilities
Complete a variety of routine MR procedures to include common and specialty MR exams of moderate complexity
Provide direct assistance to physicians with all diagnostic and special MR procedures
Deliver exceptional patient care and adhere to MR exam standards and guidelines established by governing agencies to ensure optimal patient safety and customer service
Work in the inpatient, emergency room, and hybrid operating room settings
Qualification
Required
Completion of MRI training program to include UTMB MR Training Program
0+ years of experience
American Heart Association (BLS)
American Registry of Radiologic Technologists (ARRT-MR) or American Registry of Magnetic Resonance Imaging Technologists (ARMRIT)
Must be MRI certified or MRI registry-eligible at the time of hire
Registry-eligible candidates are required to obtain MRI certification through the American Registry of Radiologic (ARRT) or an equivalent certifying (ex. ARMRIT) body within six (6) months of hire
Company
The University of Texas Medical Branch
The University of Texas Medical Branch is a component of the University of Texas System located in Galveston, Texas
H1B Sponsorship
The University of Texas Medical Branch has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (73)
2024 (66)
2023 (52)
2022 (57)
2021 (49)
2020 (50)
Funding
Current Stage
Late StageTotal Funding
$35MKey Investors
National Institute of Allergy and Infectious Diseases
2024-09-13Grant
2019-04-09Grant· $35M
Recent News
2025-10-30
Quetzal Therapeutics
2025-09-17
EIN Presswire
2025-08-25
Company data provided by crunchbase